Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus Prophylaxis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02878330
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 1,453
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Large-scale testing (Phase 3)Study completedNCT05071313
What this trial is testing

An Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Who this might be right for
Influenza, Human PreventionRespiratory Syncytial Viruses Prevention
Janssen Vaccines & Prevention B.V. 777
Testing effectiveness (Phase 2)Looking for participantsNCT06597916
What this trial is testing

RSV Vaccination in Immunocompromised Patients.

Who this might be right for
RSV Infection
Medical University of Vienna 200
Testing effectiveness (Phase 2)Looking for participantsNCT07762014
What this trial is testing

RBCG-N-RSV Vaccine in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection PreventionTuberculosis Prevention
Biothervax SpA 200
Early research (Phase 1)Study completedNCT03473002
What this trial is testing

A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults

Who this might be right for
Antiviral ProphylaxisRespiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 21
Large-scale testing (Phase 3)Study completedNCT00121108
What this trial is testing

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States

Who this might be right for
Healthy
MedImmune LLC 2,127
Large-scale testing (Phase 3)Study completedNCT06083623
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Zhuhai Trinomab Pharmaceutical Co., Ltd. 2,282
Not applicableStudy completedNCT02016690
What this trial is testing

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie 312
Large-scale testing (Phase 3)Study completedNCT05101486
What this trial is testing

An Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Vaccines & Prevention B.V. 755
Testing effectiveness (Phase 2)Ended earlyNCT02508194
What this trial is testing

Evaluate the Efficacy of MEDI7510 in Older Adults

Who this might be right for
Respiratory Syncytial Virus
MedImmune LLC 1,900
Post-approval studies (Phase 4)Study completedNCT00001903
What this trial is testing

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Study completedNCT06583031
What this trial is testing

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

Who this might be right for
RSV InfectionhMPV
Sanofi Pasteur, a Sanofi Company 385
Not applicableStudy completedNCT01545245
What this trial is testing

Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants

Who this might be right for
Atopic AsthmaRecurrent Wheezing
Tokai University 343
Large-scale testing (Phase 3)Ended earlyNCT05242432
What this trial is testing

Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Pharmaceutical K.K. 2,192
Early research (Phase 1)UnknownNCT02958540
What this trial is testing

Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine

Who this might be right for
Respiratory Syncytial Viral Infections
Mucosis BV 48
Not applicableStudy completedNCT00384462
What this trial is testing

Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 346
Testing effectiveness (Phase 2)Active Not RecruitingNCT07208461
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection Prevention
Guangzhou Patronus Biotech Co., Ltd. 700
Large-scale testing (Phase 3)Ended earlyNCT04605159
What this trial is testing

A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 11,194
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation